about
Rapid and simultaneous quantification of levetiracetam and its carboxylic metabolite in human plasma by liquid chromatography tandem mass spectrometryExternal Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.Renal targeting potential of a polymeric drug carrier, poly-l-glutamic acid, in normal and diabetic rats.Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia.Postoperative sore throat and ketamine gargle.Does Helicobacter pylori infection affect gastric emptying in patients with functional dyspepsia?Pre-admission therapy for childhood acute diarrhoea--a hospital-based study.Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants.Valproate-induced reversible sensorineural hearing loss: a case report with serial audiometry and pharmacokinetic modelling during a valproate rechallenge.In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?Evaluation of the quality of acute pain management in a pediatric surgical setting: Validation of a parent proxy modified version of the revised American Pain Society Patient Outcome QuestionnaireOmeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pyloriSlow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosisVancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing RecommendationsPopulation pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants
P50
Q28544793-EA511042-E404-49E6-B003-747432321156Q36729959-1C7792A9-F4AC-4F85-870D-4EDF3A74A4ADQ37594652-3CAA5744-C338-4550-8E41-6BFEBCD71C6EQ39567501-66005230-9BA8-4E4E-9282-C2C78D27FB37Q43020758-A7D3D4E4-9E06-427E-BB01-72EDCC6467DFQ43823616-54D0A41E-5EA2-41C8-9CC8-0E830E2DA7B7Q46173762-B8C9A2A8-8A96-4366-9D72-EA0E0497C1E9Q47797204-169220D7-608B-4185-945B-383C348394CCQ48578555-1D294A4F-F21E-4020-BC6E-80AD74B50CBAQ50948442-76403988-994B-4D06-950F-DDB816260886Q54131630-E480E587-2BD8-4719-9BDC-ECCF22354269Q58090667-348D0875-5BBB-43AF-80B8-83223A37C1A8Q72760294-C4FA1AF1-5A9F-421D-84B3-1007EB04F98CQ86957321-613148D4-E4A9-464C-8B66-750C20936241Q91104430-5382CBEB-6911-431B-9552-B6AA5737F7F7Q91719355-55A8DEEF-4659-42F6-932C-43DE9800F7D4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yoke-Lin Lo
@ast
Yoke-Lin Lo
@en
Yoke-Lin Lo
@es
Yoke-Lin Lo
@nl
Yoke-Lin Lo
@sl
type
label
Yoke-Lin Lo
@ast
Yoke-Lin Lo
@en
Yoke-Lin Lo
@es
Yoke-Lin Lo
@nl
Yoke-Lin Lo
@sl
altLabel
YL Lo
@en
prefLabel
Yoke-Lin Lo
@ast
Yoke-Lin Lo
@en
Yoke-Lin Lo
@es
Yoke-Lin Lo
@nl
Yoke-Lin Lo
@sl
P1053
B-8879-2010
P106
P31
P3829
P496
0000-0001-5521-2543